Adalimumab in Psoriasis: How Much Is Enough?

被引：7

作者：

Billi, Allison C. ^{[1
]}

Gudjonsson, Johann E. ^{[1
]}

机构：

[1] Univ Michigan, Dept Dermatol, 6427C Med Sci 1,1301 Catherine, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 01期

关键词：

D O I：

10.1016/j.jid.2018.08.012

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Biologic therapies targeting tumor necrosis factor have revolutionized treatment of immune-mediated inflammatory diseases such as psoriasis, but optimal dosing and appropriate use of therapeutic drug monitoring are not yet fully understood. Wilkinson et al. explore these questions in a real-world psoriasis cohort on adalimumab monotherapy, defining a therapeutic range and finding value in early measurement for predicting clinical response.

引用

页码：19 / 22

页数：4

共 14 条

[1]

Blackstone Erwin A, 2012, Biotechnol Healthc, V9, P24

[2] TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis [J].

Conrad, Curdin ;

Di Domizio, Jeremy ;

Mylonas, Alessio ;

Belkhodja, Cyrine ;

Demaria, Olivier ;

Navarini, Alexander A. ;

Lapointe, Anne-Karine ;

French, Lars E. ;

Vernez, Maxime ;

Gilliet, Michel .

NATURE COMMUNICATIONS, 2018, 9

[3] American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease [J].

Feuerstein, Joseph D. ;

Nguyen, Geoffrey C. ;

Kupfer, Sonia S. ;

Falck-Ytter, Yngve ;

Singh, Siddharth .

GASTROENTEROLOGY, 2017, 153 (03) :827-834

[4]

Mahil SK, 2013, BRIT J DERMATOL, V169, P1170, DOI 10.1111/bjd.12511

[5] Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis A Step Toward Personalized Treatment [J].

Menting, Stef P. ;

Coussens, Emma ;

Pouw, Mieke F. ;

van den Reek, Juul M. P. A. ;

Temmerman, Linda ;

Boonen, Hugo ;

de Jong, Elkem. G. J. ;

Spuls, Phyllis I. ;

Lambert, Jo .

JAMA DERMATOLOGY, 2015, 151 (06) :616-622

[6] TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis [J].

Noti, Mario ;

Corazza, Nadia ;

Mueller, Christoph ;

Berger, Barbara ;

Brunner, Thomas .

JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (05) :1057-1066

[7] Key findings towards optimising adalimumab treatment: the concentration-effect curve [J].

Pouw, Mieke F. ;

Krieckaert, Charlotte L. ;

Nurmohamed, Michael T. ;

van der Kleij, Desiree ;

Aarden, Lucien ;

Rispens, Theo ;

Wolbink, Gertjan .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) :513-518

[8] Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases [J].

Roblin, Xavier ;

Rinaudo, M. ;

Del Tedesco, E. ;

Phelip, J. M. ;

Genin, C. ;

Peyrin-Biroulet, L. ;

Paul, S. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (08) :1250-1256

[9] Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation [J].

Sarkar, Mrinal K. ;

Kaplan, Nihal ;

Tsoi, Lam C. ;

Xing, Xianying ;

Liang, Yun ;

Swindell, William R. ;

Hoover, Paul ;

Aravind, Maya ;

Baida, Gleb ;

Clark, Matthew ;

Voorhees, John J. ;

Nair, Rajan P. ;

Elder, James T. ;

Budunova, Irina ;

Getsios, Spiro ;

Gudjonsson, Johann E. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (07) :1474-1483

[10]

Vande Casteele N, 2017, GASTROENTEROLOGY, V153, pe6, DOI DOI 10.1053/J.GASTR0.2017.07.031

← 1 2 →